32 results on '"Yang, Sherry X."'
Search Results
2. Locoregional tumor burden and risk of mortality in metastatic breast cancer
3. Upregulation of TET2 and Resistance to DNA Methyltransferase (DNMT) Inhibitors in DNMT1 -Deleted Cancer Cells.
4. TET2 and DNMT3A mutations and exceptional response to 4′-thio-2′-deoxycytidine in human solid tumor models
5. Abstract LB119: Recurrence score for recurrence over survival outcome in the landmark TAILORx trial
6. Abstract P2-11-09: Association of 21-gene recurrence score with overall survival in phase 3 TAILORx trial
7. Development and Validation of a Nomogram for Early Detection of Malignant Gallbladder Lesions
8. Abstract LB192: Demethylation, DNA damage and antitumor activity of DNA methyltransferase inhibitors in models with intact and disrupted DNMT1 gene
9. Additional file 1 of TET2 and DNMT3A mutations and exceptional response to 4′-thio-2′-deoxycytidine in human solid tumor models
10. The VEGF Inhibitor Axitinib Has Limited Effectiveness as a Therapy for Adrenocortical Cancer
11. Abstract LB-107: TET2/DNMT3A mutations and exceptional response to novel epigenetic agent in human malignancies
12. Association of Independent Prognostic Factors and Treatment Modality With Survival and Recurrence Outcomes in Breast Cancer
13. Expression of Gli1 in the hedgehog signaling pathway and breast cancer recurrence
14. Association of γH2AX at Diagnosis with Chemotherapy Outcome in Patients with Breast Cancer
15. Abstract B12: DNA methyltransferase 3A expression in cancer cells following treatment with DNMT inhibitors and in human solid tumors
16. Notch1 phenotype and clinical stage progression in non-small cell lung cancer
17. Abstract 3838: Differential expression of Notch1 in lung, ovarian and breast cancers
18. The VEGF Inhibitor Axitinib Has Limited Effectiveness as a Therapy for Adrenocortical Cancer
19. Identification and Analysis of In Vivo VEGF Downstream Markers Link VEGF Pathway Activity with Efficacy of Anti-VEGF Therapies
20. Abstract 2424: CD40 expression in human solid tumors and NCI60 tumor cell lines.
21. Abstract 746: Notch-1 expression in human cancer cell lines and solid tumors by validated immunohistochemistry
22. DNA Methyltransferase Inhibitor, Zebularine, Delays Tumor Growth and Induces Apoptosis in a Genetically Engineered Mouse Model of Breast Cancer
23. Poly(ADP-ribose) polymerase inhibition enhances p53-dependent and -independent DNA damage responses induced by DNA damaging agent
24. Abstract 3637: Sensitivity of breast cancer cell lines with distinct genotypes to poly(ADP-ribose) polymerase inhibitor or in combination with DNA damaging agents
25. Reply to the Letter to the Editor from Jubb
26. Gene Expression Profile and Angiogenic Markers Correlate with Response to Neoadjuvant Bevacizumab Followed by Bevacizumab plus Chemotherapy in Breast Cancer
27. Designing Phase 0 Cancer Clinical Trials
28. Cardiac Toxicity and Efficacy of Trastuzumab Combined with Pertuzumab in Patients with Trastuzumab-Insensitive Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer
29. Circulating biomarkers of bevacizumab activity in patients with breast cancer
30. Gene Expression Patterns and Profile Changes Pre- and Post-Erlotinib Treatment in Patients with Metastatic Breast Cancer
31. Immunohistochemical detection of poly(ADP-ribose) polymerase inhibition by ABT-888 in patients with refractory solid tumors and lymphomas
32. Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with [corrected] human epidermal growth factor receptor 2-positive metastatic breast cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.